デフォルト表紙
市場調査レポート
商品コード
1439962

吻合装置の世界市場:洞察、競合情勢、市場予測:2030年

Anastomosis Device - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
吻合装置の世界市場:洞察、競合情勢、市場予測:2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の吻合装置の市場規模は、2024年から2030年までの予測期間中に5.3%のCAGRで拡大すると予測されています。吻合装置市場は、主に冠動脈バイパス移植手術(CABG)と回腸吻合術の増加により、著しい市場成長を観察しています。さらに、冠動脈疾患、胃疾患、慢性腎臓病の有病率の上昇、デバイスの技術的進歩の増加、高齢者患者の負担の急増、製品の発売や承認の増加などが、市場における吻合装置の必要性を生み出しています。

吻合装置市場の成長に影響を与える主な要因の1つは、世界中で冠動脈性心疾患の有病率が上昇していることです。疾病予防管理センター(CDC)が発表した2023年のデータによると、冠動脈性心疾患は米国で最も一般的な心臓病のタイプであり、2020年の死亡者数は38万2,820人でした。心血管疾患を減らす鍵は、吻合装置を含む様々な外科的処置を通して行うことができる心血管疾患管理介入を含めることにあります。従って、冠動脈疾患の症例の増加は、手術後に血管や動脈を密閉するための吻合装置を必要とする外科手術の数を増やし、最終的に心臓血管外科における吻合装置の使用を増加させるとみられています。

さらに、動脈硬化の有病率の増加も、市場における吻合装置の需要を増加させる可能性があります。アテローム性動脈硬化症は、動脈壁の内側にプラークが蓄積することによって引き起こされ、手術によって除去する必要があります。動脈硬化治療の場合、両動脈を接合するための吻合装置が必要になることがあるため、外科手術の増加により吻合装置の需要が増加します。

当レポートでは、世界の吻合装置市場について調査し、市場の概要とともに、製品別、使用法別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 吻合装置市場レポートのイントロダクション

第2章 吻合装置市場のエグゼクティブサマリー

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 吻合装置市場の主な要因分析

  • 吻合装置市場の促進要因
  • 吻合装置市場の抑制要因と課題
  • 吻合装置市場の機会

第5章 吻合装置市場におけるポーターのファイブフォース分析

第6章 吻合装置市場に対するCOVID-19の影響分析

第7章 吻合装置の市場概要

  • 製品別
  • 使いやすさ別
  • 用途別
  • エンドユーザー別
  • 地域別

第8章 吻合装置市場の企業と製品プロファイル

  • Intuitive Surgical
  • B. Braun SE
  • BAXTER
  • CryoLife, Inc
  • JOHNSON & JOHNSON
  • Medtronic
  • Sinolinks Medical Innovation, Inc.
  • microcuremed
  • BIOWIN PHARMACEUTICAL CO., LIMITED
  • Waston Medical Corporation
  • W. L. Gore & Associates, Inc.
  • Hangzhou Demo Medical Technology Co., Ltd
  • BD.
  • Dolphin Sutures
  • gpcmedical
  • Golden Stapler Surgical Co., Ltd.
  • JIANGSU JOYMED TECH CO., LTD
  • Changzhou Haiers Medical Devices Co., Ltd
  • Shanghai MedEco Industry Co., Ltd
  • ChangZhou WeiPu Medical Devices CO., LTD

第9章 KOL の見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Anastomosis Device Market
  • Table 3: Anastomosis Device Market Analysis in Global (2021-2030)
  • Table 4: Anastomosis Device Market Analysis in Global by Product (2021-2030)
  • Table 5: Anastomosis Device Market Analysis in Global by Usability (2021-2030)
  • Table 6: Anastomosis Device Market Analysis in Global by Application (2021-2030)
  • Table 7: Anastomosis Device Market Analysis in Global by End-User (2021-2030)
  • Table 8: Anastomosis Device Market Analysis in Global by Geography (2021-2030)
  • Table 9: Anastomosis Device Market Analysis in North America (2021-2030)
  • Table 10: Anastomosis Device Market Analysis in North America by Country (2021-2030)
  • Table 11: Anastomosis Device Market Analysis in the US (2021-2030)
  • Table 12: Anastomosis Device Market Analysis in Canada (2021-2030)
  • Table 13: Anastomosis Device Market Analysis in Mexico (2021-2030)
  • Table 14: Anastomosis Device Market Analysis in Europe (2021-2030)
  • Table 15: Anastomosis Device Market Analysis in Europe by Country (2021-2030)
  • Table 16: Anastomosis Device Market Analysis in France (2021-2030)
  • Table 17: Anastomosis Device Market Analysis in Germany (2021-2030)
  • Table 18: Anastomosis Device Market Analysis in the UK (2021-2030)
  • Table 19: Anastomosis Device Market Analysis in Italy (2021-2030)
  • Table 20: Anastomosis Device Market Analysis in Spain (2021-2030)
  • Table 21: Anastomosis Device Market Analysis in the Rest of Europe (2021-2030)
  • Table 22: Anastomosis Device Market Analysis in Asia-Pacific (2021-2030)
  • Table 23: Anastomosis Device Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 24: Anastomosis Device Market Analysis in China (2021-2030)
  • Table 25: Anastomosis Device Market Analysis in Japan (2021-2030)
  • Table 26: Anastomosis Device Market Analysis in India (2021-2030)
  • Table 27: Anastomosis Device Market Analysis in Australia (2021-2030)
  • Table 28: Anastomosis Device Market Analysis in South Korea (2021-2030)
  • Table 29: Anastomosis Device Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Table 30: Anastomosis Device Market Analysis in the Rest of the World (2021-2030)
  • Table 31: Anastomosis Device Market Analysis in the Rest of the World by Region (2021-2030)
  • Table 32: Anastomosis Device Market Analysis in the Middle East (2021-2030)
  • Table 33: Anastomosis Device Market Analysis in Africa (2021-2030)
  • Table 34: Anastomosis Device Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Anastomosis Device Market
  • Figure 3: Anastomosis Device Market Analysis in Global (2021-2030)
  • Figure 4: Anastomosis Device Market Analysis in Global by Product (2021-2030)
  • Figure 5: Anastomosis Device Market Analysis in Global by Usability (2021-2030)
  • Figure 6: Anastomosis Device Market Analysis in Global by Application (2021-2030)
  • Figure 7: Anastomosis Device Market Analysis in Global by End-User (2021-2030)
  • Figure 8: Anastomosis Device Market Analysis in Global by Geography (2021-2030)
  • Figure 9: Anastomosis Device Market Analysis in North America (2021-2030)
  • Figure 10: Anastomosis Device Market Analysis in North America by Country (2021-2030)
  • Figure 11: Anastomosis Device Market Analysis in the US (2021-2030)
  • Figure 12: Anastomosis Device Market Analysis in Canada (2021-2030)
  • Figure 13: Anastomosis Device Market Analysis in Mexico (2021-2030)
  • Figure 14: Anastomosis Device Market Analysis in Europe (2021-2030)
  • Figure 15: Anastomosis Device Market Analysis in Europe by Country (2021-2030)
  • Figure 16: Anastomosis Device Market Analysis in France (2021-2030)
  • Figure 17: Anastomosis Device Market Analysis in Germany (2021-2030)
  • Figure 18: Anastomosis Device Market Analysis in the UK (2021-2030)
  • Figure 19: Anastomosis Device Market Analysis in Italy (2021-2030)
  • Figure 20: Anastomosis Device Market Analysis in Spain (2021-2030)
  • Figure 21: Anastomosis Device Market Analysis in the Rest of Europe (2021-2030)
  • Figure 22: Anastomosis Device Market Analysis in Asia-Pacific (2021-2030)
  • Figure 23: Anastomosis Device Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 24: Anastomosis Device Market Analysis in China (2021-2030)
  • Figure 25: Anastomosis Device Market Analysis in Japan (2021-2030)
  • Figure 26: Anastomosis Device Market Analysis in India (2021-2030)
  • Figure 27: Anastomosis Device Market Analysis in Australia (2021-2030)
  • Figure 28: Anastomosis Device Market Analysis in South Korea (2021-2030)
  • Figure 29: Anastomosis Device Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Figure 30: Anastomosis Device Market Analysis in the Rest of the World (2021-2030)
  • Figure 31: Anastomosis Device Market Analysis in the Rest of the World by Region (2021-2030)
  • Figure 32: Anastomosis Device Market Analysis in the Middle East (2021-2030)
  • Figure 33: Anastomosis Device Market Analysis in Africa (2021-2030)
  • Figure 34: Anastomosis Device Market Analysis in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Market Opportunities
  • Figure 38: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0643

Anastomosis Device Market By Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, And Surgical Adhesives), By Usability (Disposable And Reusable), By Application (Cardiovascular Surgery, Gastrointestinal Surgery, And Others), By End-User (Hospitals & Clinics, Ambulatory Care Centres, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of cardiovascular, gastrointestinal disease, & chronic kidney diseases and the increasing technological advancements in the device

The global anastomosis device market is estimated to grow at a CAGR of 5.3% during the forecast period from 2024 to 2030. The anastomosis device market is observing remarkable market growth primarily due to the increasing number of coronary bypass graft surgery (CABG) and Ileocolic anastomosis. Further, the rising prevalence of coronary disease, gastric disease, and chronic kidney disease, the increasing technological advancements in the device, the up-surging burden of elderly patients, the increasing product launches, approvals, and others will create a necessity for the anastomosis device in the market. Therefore, the market for anastomosis devices is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Anastomosis Device Market Dynamics:

One of the key factors influencing the growth of the anastomosis device in the market is the increasing prevalence of coronary heart disease across the world. According to 2023 data published by the Centers for Disease and Prevention Control (CDC), coronary heart disease is the most common type of heart disease in the US and accounted for 382,820 deaths in 2020. The key to cardiovascular disease reduction lies in the inclusion of cardiovascular disease management interventions which can be done through various surgical procedures that may involve anastomosis devices. Thus, the increasing cases of coronary heart disease will increase the number of surgical procedures which may require anastomosis devices for sealing the vessel and arteries after the surgery, ultimately increasing the use of anastomosis in cardiovascular surgery.

Further, the increasing prevalence of atherosclerosis can also increase the demand for anastomosis devices in the market. Atherosclerosis is caused by a build-up of plaque in the inner lining of an artery wall, which needs removal through surgery. The surgery may need an anastomosis device for joining both arteries in case of arteriosclerosis treatment, thus the increasing number of surgical procedures will increase the demand for anastomosis devices.

Elderly patients are more prone to various chronic diseases such as chronic kidney diseases, coronary vascular diseases, obesity, atherosclerosis, and others. For instance, the latest study conducted by Heart Research Institute concluded that over the age of 40, people in general good health have about a 50% chance of developing serious atherosclerosis, with this risk increasing with age. Most people over the age of 60 have some atherosclerosis and need surgery for removing plaque. Thus after atherosclerosis managing surgical procedure, vessels need a connection that can be made by sealants or staplers, ultimately increasing the demand for anastomosis devices.

According to the American Cancer Society 2020-2022, an estimated 104,610 new cases of colon cancer and 43,340 cases of rectal cancer were diagnosed in the US in 2020. Colon cancer may need surgery for treatment which further may need an anastomosis device for connecting the leftover vessel part of the colon to each other. Thus, the increasing prevalence of colon cancer will increase the surgical number which treats colon cancer, thereby increasing the demand for anastomosis devices.

Therefore, the factors stated above collectively will drive the overall anastomosis device market during the forecast period from 2024-2030.

However, the complications due to anastomosis, the increasing demand for minimally invasive or non-invasive treatment approaches, and others may prove to be challenging factors for anastomosis device market growth.

The anastomosis device market was negatively impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitalizations and surgical procedures for chronic disorders such as cancers, diabetes, cardiovascular disorders, stroke, and others. This resulted in a reduced number of patients in hospitals or surgical centers. Additionally, the restrictions on the supply chain, raw materials, and other resources halted the manufacturing of devices, leading to a shortage of treatment devices in the market. However, the vaccine development of COVID-19 initiated the process of economic recovery. Also, the easing of lockdown restrictions and the return of normal life in the economic landscape initiated the process of resumption of regular healthcare services such as patient visits and surgeries for the treatment of aforementioned ailments, thereby bringing the demand for anastomosis devices on track.

Anastomosis Device Market Segment Analysis:

Anastomosis device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Ambulatory Care Centers, Hospitals and Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the anastomosis device market, the surgical staplers segment is expected to have a revenue share of XX in the year 2023. This was primarily owing to the rising focus of manufacturers towards developing technologically advanced surgical staplers for an improved and efficient connection of vessels and the other various advantages offered by the category.

The surgical staplers provide quick placement, minimal tissue reaction, low risk of infection, and strong wound closure in patients with cardiovascular and gastrointestinal diseases. The staplers are also available in different shapes and sizes, easing the process of closure during surgery.

Further, the increasing product launches and regulatory approvals of the anastomosis device will aid in increasing its demand in the market. For instance, in March 2022, FDA approved Viola clamps, a less proximal anastomosis device, and a new device for clamp proximal anastomosis in coronary artery bypass grafting (CABG).

Therefore, owing to the aforementioned factors, the surgical staplers category is expected to witness considerable growth eventually contributing to the overall growth of the global anastomosis device market during the forecast period.

North America is expected to dominate the overall Anastomosis Device Market:

Among all the regions, North America is expected to hold the largest share of the anastomosis device market in 2022 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the growing government initiatives to raise effective management of coronary bypass graft surgery, the rising demand for fistula for dialysis treatment, the expanding burden of elderly patients prone to various cardiovascular disorders, the increasing prevalence of kidney diseases, increasing product launches, and the presence of advanced healthcare facilities in the region, which will boost the anastomosis market in North America during the forecast period.

For instance, as per the Centre for Disease and Prevention Control (CDC), in 2022, 20.1 million Americans aged 20 years and older were affected by coronary heart disease (CHD) 2020. Additionally, as per the same source, every year nearly about 805,000 Americans experience a heart attack. This figure of heart attack can be controlled by providing proper treatment for CHD. The treatment of CHD will need surgery in which two vessels or arteries might be requiring a closure which can be done by an anastomosis device. Thus, the increasing prevalence of CHD in the country will increase the number of surgical procedures, thereby increasing the demand for anastomosis devices in the region.

According to the United States Renal Data System 2020 Annual Data Report, nearly 786,000 people in the United States were living with end-stage renal disease (ESRD) and 71% of them were on dialysis. Dialysis patients need vascular access for dialysis therapy, this vascular access is made by the connection of artery and vein, which is called arteriovenous anastomosis. This procedure is primarily done by anastomosis devices. Thus, the increasing number of dialysis procedures will increase the number of arteriovenous anastomoses, ultimately increasing the demand for anastomosis devices. Thus, the increasing prevalence of chronic kidney disease will also increase the market for anastomosis disease in the North America region.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the anastomosis device market.

Anastomosis Device Market Key Players:

Some of the key market players operating in the anastomosis device market include Intuitive Surgical, B. Braun SE, BAXTER, CryoLife, Inc, JOHNSON & JOHNSON, SURGIVALLEY, Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc, Hangzhou Demo Medical Technology Co., Ltd, BD., Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

Recent Developmental Activities in the Anastomosis Device Market:

In February 2022, Vascular Graft Solutions Ltd. received a receipt of marketing authorization from the FDA for VIOLA. This is a new device for clampless proximal anastomosis in CABG.

In March 2022, Johnson & Johnson launched the ECHELON Stapler which is a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression.

In April 2022, Ethicon announced the global launch of a new powered surgical stapler, with gripping surface technology.

In December 2020, Medtronic Private Limited announced the launch of the EEA(TM) Circular Stapler with Tri-Staple(TM) Technology. The device has three rows of varied height staples to deliver 30 percent more security to the staple line and requires 60 percent lesser firing force in the operating room as compared to current devices.

Key Takeaways from the Anastomosis Device Market Report Study

Market size analysis for current anastomosis device market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the anastomosis device market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global anastomosis device market.

Various opportunities are available for the other competitor in the anastomosis device market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current anastomosis device market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for anastomosis device market growth in the coming future?

Target Audience who can be benefited from this Anastomosis Device Market Report Study

Anastomosis devise products providers

Research organizations and consulting companies

Anastomosis device-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in anastomosis device

Various end users who want to know more about the anastomosis device market and the latest technological developments in the anastomosis device market.

Frequently Asked Questions for the Anastomosis Device Market:

1. What is an anastomosis device?

The anastomosis device is used for making the surgical connection between two tubular structures, such as blood vessels or loops of the intestine. An anastomosis is a surgical procedure that involves connecting two structures and is performed after the resection of an organ to connect the remaining sections.

2. What is the global market for anastomosis devices?

The global anastomosis device market is estimated to grow at a CAGR of 5.3% during the forecast period from 2024 to 2030.

3. What are the drivers for the global anastomosis device market?

The anastomosis device market is witnessing positive market growth owing to the factors such as the rising prevalence of coronary artery disease, arteriosclerosis, and chronic kidney disease, the growing burden of the elderly population, the increasing product launches and approvals, the presence of key players in the market, and others will create an exigency for the anastomosis device market.

4. Who are the key players operating in the global anastomosis device market?

Some of the key market players operating in the anastomosis device market include Intuitive Surgical, B. Braun SE, BAXTER, CryoLife, Inc, JOHNSON & JOHNSON, SURGIVALLEY, Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc, Hangzhou Demo Medical Technology Co., Ltd, BD., Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

5. Which region has the highest share in the anastomosis device market?

Among all the regions, North America is estimated to amass a significant revenue share in the global anastomosis device market. This can be ascribed to the growing cases of coronary bypass graft surgery, the rising burden of elderly patients, the increasing prevalence of chronic kidney disease, the presence of advanced healthcare facilities in the region, and others that act as a supportive factor for the North America anastomosis device market growth.

Table of Contents

1.Anastomosis Device Market Report Introduction

2. Anastomosis Device Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Anastomosis Device Market Key Factors Analysis

  • 4.1. Anastomosis Device Market Drivers
    • 4.1.1. Rising number of surgical procedures owing to the prevalence of coronary artery disease, arteriosclerosis, and other diseases
    • 4.1.2. Rising cases of dialysis which need arteriovenous fistula
    • 4.1.3. Availability of technologically advanced products in the market
  • 4.2. Anastomosis Device Market Restraints and Challenges
    • 4.2.1. Complications due to anastomosis
    • 4.2.2. Increasing demand for the minimally invasive or non-invasive treatment approach
  • 4.3. Anastomosis Device Market Opportunities
    • 4.3.1. Incorporation of automatic anastomosis devices such as robotic surgical staplers and others

5. Anastomosis Device Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Anastomosis Device Market

7. Anastomosis Device Market Layout

  • 7.1. By Product
    • 7.1.1. Surgical Staplers
    • 7.1.2. Surgical Sutures
    • 7.1.3. Surgical Sealants
    • 7.1.4. Surgical Adhesives
  • 7.2. By Usability
    • 7.2.1. Disposable
    • 7.2.2. Reusable
  • 7.3. By Application
    • 7.3.1. Cardiovascular surgery
    • 7.3.2. Gastrointestinal surgery
    • 7.3.3. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals & clinics
    • 7.4.2. Ambulatory surgical centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America Anastomosis Device Market Size in USD million (2021-2030)
      • 7.5.1.1. United States Anastomosis Device Market in USD million (2021-2030)
      • 7.5.1.2. Canada Anastomosis Device Market in USD million (2021-2030)
      • 7.5.1.3. Mexico Anastomosis Device Market in USD million (2021-2030)
    • 7.5.2. Europe Anastomosis Device Market Size in USD million (2021-2030)
      • 7.5.2.1. France Anastomosis Device Market in USD million (2021-2030)
      • 7.5.2.2. Germany Anastomosis Device Market in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Anastomosis Device Market in USD million (2021-2030)
      • 7.5.2.4. Italy Anastomosis Device Market in USD million (2021-2030)
      • 7.5.2.5. Spain Anastomosis Device Market in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Anastomosis Device Market in USD million (2021-2030)
    • 7.5.3. Asia-Pacific Anastomosis Device Market Size in USD million (2021-2030)
      • 7.5.3.1. China Anastomosis Device Market in USD million (2021-2030)
      • 7.5.3.2. Japan Anastomosis Device Market in USD million (2021-2030)
      • 7.5.3.3. India Anastomosis Device Market in USD million (2021-2030)
      • 7.5.3.4. Australia Anastomosis Device Market in USD million (2021-2030)
      • 7.5.3.5. South Korea Anastomosis Device Market in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia Pacific Anastomosis Device Market in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW) Anastomosis Device Market Size in USD million (2021-2030)
      • 7.5.4.1. Middle East Anastomosis Device Market in USD million (2021-2030)
      • 7.5.4.2. Africa Anastomosis Device Market in USD million (2021-2030)
      • 7.5.4.3. South America Anastomosis Device Market in USD million (2021-2030)

8. Anastomosis Device Market Company and Product Profiles

  • 8.1. Intuitive Surgical
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. B. Braun SE
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. BAXTER
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. CryoLife, Inc
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. JOHNSON & JOHNSON
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Medtronic
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Sinolinks Medical Innovation, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. microcuremed
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. BIOWIN PHARMACEUTICAL CO., LIMITED
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Waston Medical Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. W. L. Gore & Associates, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Hangzhou Demo Medical Technology Co., Ltd
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. BD.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Dolphin Sutures
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. gpcmedical
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Golden Stapler Surgical Co., Ltd.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. JIANGSU JOYMED TECH CO., LTD
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Changzhou Haiers Medical Devices Co., Ltd
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Shanghai MedEco Industry Co., Ltd
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. ChangZhou WeiPu Medical Devices CO., LTD
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us